Blue Horseshoe Stocks: GSK Recap & More

GlaxoSmithKline plc GSK – Update

We attempted to keep our excellent 2019 options performance intact yesterday, and we did see some chances for intraday gains in the fresh idea for GSK we included in our premarket report.

The stock didn’t skyrocket by any means, rising by less than a dollar, but the activity was sufficient to produce the following moves in our designated contracts.

$39.50 Calls – Range: .65-1.24 – Max Gain: 91%
$40 Calls – Range: .15-.75 – Max Gain: 400%
$40.50 Calls – Range: .10-.40 – Max Gain: 300%
_____

Fresh Idea:
GRUB Weekly $86-87.50 Calls


Calix, Inc. CALX &
Vanda Pharmaceuticals, Inc. VNDA

We want to group these two stocks together this morning and tag them as bottom-watch plays. We’ll observe for the establishment of higher lows after their recent selloffs.

Both are now in the position of being extremely oversold, and exhibiting many of the conditions we routinely look for in potential recovery plays. We’ll observe their activity as we head into the end of the week.


Extended Watchlist:
DRVD, PYDS, NVCN, TPNL, BIOC

Blue Horseshoe Stocks: UAA Update & More

Under Armour, Inc. UAA – Update

We mentioned the possibility of further gains for the calls we signaled in the Under Armour options chain on Tuesday, the UAA Weekly $15.50-16.50 Calls.

The markets pulled a head-fake, and ended up going green, which helped allow the stock to make to more than $18. That created huge opportunities in our highlighted plays, which went quickly from double-baggers on Tuesday, to a triple, a quad, and even an octuple-bagger!

$15.50 Calls – Range: .60-2.50 – Max Gain: 317%
$16 Calls – Range: .34-2.00 – Max Gain: 488%
$16.50 Calls – Range: .16-1.50 – Max Gain: 838%

______

Fresh Options Idea:
SPY Weekly $270-272 Calls



Payment Data Systems, Inc. PYDS

We are looking at PYDS as a bottom-bouncer with just the kind of chart setup we like. The stock spent nearly all of January and the beginning of February under heavy consolidation down to its lowest PPS since October. In the last couple of weeks it has shown signs of a solid turnaround.

As you can see below, the RSI is coming off of being oversold and presently cruising toward the 50-line,  the MACD is in the midst of a bullish cross, and yesterday saw the testing of the 200DMA. PYDS also has a recent history of rapid runs up the chart, also visible on the included snapshot, so we’ll be keeping a close eye on it in the coming days.


Extended Watchlist:
CSCO, MNOV, MBRX, TEVA, RIOT, HIIQ, SBCF, OMF